CD20 x CD3 drugs for Diffuse Large B-Cell Lymphoma
2 tracked CD20 x CD3 drugs in the Diffuse Large B-Cell Lymphoma race. The class explanation lives on the CD20 x CD3 page; the full indication pipeline across every mechanism is on the Diffuse Large B-Cell Lymphoma page.
1 approved / phase 41 Phase 3